Monoclonal antibody fluorescent polarisation immunoassay versus 125Iode labelled ligand radioimmunoassay for the measurement of cyclosporine concentrations in whole blood
- 26 August 1991
- journal article
- research article
- Published by Wiley in Fundamental & Clinical Pharmacology
- Vol. 5 (6) , 557-562
- https://doi.org/10.1111/j.1472-8206.1991.tb00742.x
Abstract
Monoclonal antibody fluorescent polarisation immunoassay for cyclosporine in whole blood was first evaluated. Inter- and intra-assay CVs were less than 7%. We also compared concentrations measured by 125I-RIA and FPIA in specimens obtained from kidney and bone marrow transplanted patients. FPIA correlated well with 125I-RIA (slope = 1.03, r = 0.989, n = 58) over a wide range of concentrations (44-984 ng/ml). However, an additive bias estimated by the mean difference in cyclosporine concentrations between the 2 readings (44.1 +/- 44.3 ng/ml), led to overestimation of cyclosporine concentrations measured by FPIA. The monoclonal FPIA kit is therefore a rapid and reproductive method to monitor cyclosporine concentrations in whole blood. However, FPIA and 125I-RIA are not interchangeable and the therapeutic range of cyclosporine measured by FPIA should be defined.Keywords
This publication has 6 references indexed in Scilit:
- Consensus Document: Hawk's Cay Meeting on Therapeutic Drug Monitoring of CyclosporineClinical Chemistry, 1990
- A validation study of selected methods routinely used for measurement of cyclosporineClinical Chemistry, 1990
- Measurement of cyclosporine concentrations in whole blood: HPLC and radioimmunoassay with a specific monoclonal antibody and 3H- or 125I-labeled ligand compared.Clinical Chemistry, 1989
- Statistical evaluation of agreement between two methods for measuring a quantitative variableComputers in Biology and Medicine, 1989